Hypoxia and the Metastatic Niche
- PMID: 31201719
- DOI: 10.1007/978-3-030-12734-3_7
Hypoxia and the Metastatic Niche
Abstract
Metastasis is considered the latest stage of cancer development; however, metastasis occurs earlier than it can be detected. Metastatic sites are actively remodeled by secretory factors including growth factors, chemokines and cytokines, extracellular matrix (ECM) enzymes, and exosomes produced by the primary cancer tissues. Many of the associated-secretory factors are abundantly induced by inflammation and hypoxia. These secretory factors modify the ECM, immune composition, and blood vessel permeability of the future metastatic sites, a process termed 'metastatic niche formation.' In general, ECM is modified to enhance the attachment of other cell types or cancer cells to establish a growth-factor rich metastatic niche. Immune-suppressive cells such as tumor-associated macrophages (TAMs) and regulatory T cells (Tregs) dominate the metastatic niche to allow metastatic cancer cells to bypass immune surveillance and propagate. Endothelial cell-to-cell junctions of blood vessels are loosened to enhance the penetrance of metastatic cancer cells to the metastatic sites. Different metastatic tissues have unique ECM constituents, resident immune cells, and anatomical positions linked with the circulatory system; therefore, many cancer types have their own metastatic pattern, and they favor metastasis to specific organs. Some of the remodeling events represent the earliest step of metastasis, even preceding the detachment of cancer cells from the primary tumor site. Understanding how the metastatic niche is formed is important for the development of drugs to prevent the earliest step of metastasis and advance our understanding of organotrophic metastasis. This review summarizes the major findings in the field of metastatic niche highlighting the role of hypoxia.
Keywords: BMDC (bone marrow-derived cell); Chemokine; Cytokine; ECM; Exosome; MDSC (myeloid-derived suppressor cell); PMN (Premetastatic niche); TAM (tumor-associated macrophage); Treg (regulatory T cell); Tumor microenvironment.
Similar articles
-
Hypoxia and the Tumor Secretome.Adv Exp Med Biol. 2019;1136:57-69. doi: 10.1007/978-3-030-12734-3_4. Adv Exp Med Biol. 2019. PMID: 31201716 Review.
-
The extracellular matrix in tumor progression and metastasis.Clin Exp Metastasis. 2019 Jun;36(3):171-198. doi: 10.1007/s10585-019-09966-1. Epub 2019 Apr 11. Clin Exp Metastasis. 2019. PMID: 30972526 Review.
-
Myeloid regulatory cells in tumor spreading and metastasis.Immunobiology. 2015 Feb;220(2):236-42. doi: 10.1016/j.imbio.2014.07.017. Epub 2014 Jul 23. Immunobiology. 2015. PMID: 25178934 Review.
-
The lung metastatic niche.J Mol Med (Berl). 2015 Nov;93(11):1185-92. doi: 10.1007/s00109-015-1355-2. J Mol Med (Berl). 2015. PMID: 26489606 Review.
-
The molecular composition of the metastatic niche.Exp Cell Res. 2013 Jul 1;319(11):1679-86. doi: 10.1016/j.yexcr.2013.04.017. Epub 2013 May 21. Exp Cell Res. 2013. PMID: 23707205 Review.
Cited by
-
Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence.Cancers (Basel). 2021 Jul 6;13(14):3388. doi: 10.3390/cancers13143388. Cancers (Basel). 2021. PMID: 34298602 Free PMC article.
-
The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis.Cells. 2019 Dec 10;8(12):1602. doi: 10.3390/cells8121602. Cells. 2019. PMID: 31835465 Free PMC article. Review.
-
Tissue-Resident Macrophages in Cancer: Friend or Foe?Cancer Med. 2024 Nov;13(21):e70387. doi: 10.1002/cam4.70387. Cancer Med. 2024. PMID: 39494816 Free PMC article. Review.
-
Identification of a Novel Prognostic Classification Model in Epithelial Ovarian Cancer by Cluster Analysis.Cancer Manag Res. 2020 Jul 24;12:6251-6259. doi: 10.2147/CMAR.S251882. eCollection 2020. Cancer Manag Res. 2020. PMID: 32801870 Free PMC article.
-
Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation.Cancers (Basel). 2022 Nov 30;14(23):5930. doi: 10.3390/cancers14235930. Cancers (Basel). 2022. PMID: 36497411 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources